Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Orthopaedics Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Orthopaedics Other
    Chronic musculoskeletal pain and the occurrence of falls in an older population - (JAMA)
    Severe Joint Pain in Multiple Areas Associated With Increased Risk of Falls in Older Adults - (DGNews)
    Rilonacept Approved in the EU for Cryopyrin-Associated Periodic Syndromes - (DGNews)
    Surgery Provides Modest Benefit Over Non-Surgical Treatment for Carpal Tunnel Syndrome - (DGNews)
    Denosumab Superior to Zoledronic Acid in Delaying Skeletal-Related Events in Breast Cancer With Bone Metastases: Presented at ECCO-ESMO - (DGDispatch)

    News archive

     Recent webcasts/CME - Orthopaedics Other
    • Optimizing Bone Health Management in Multiple Myeloma
    • Update on DVT and PE in OB Gyn/Ortho Patients
      Considerations in Pharmacy Compounding and the Treatment of Spasticity
      Differential Diagnosis and Management of Autoimmune Neuromuscular Diseases: A Case-Based Approach
      Frailty

      Webcasts/CME archive

       Recent cases - Orthopaedics Other
        Gluteal Compartment Syndrome: A Case Report
        Dynamic Splinting Home Therapy for Toe Walking: A Case Report
        A Stiff-Legged Gait: Benign Acute Childhood Myositis
        Clinical Experience of Novel Interconnected Porous Hydroxyapatite Ceramics for the Revision of Tumor Prosthesis: A Case Report
        Missed Diagnosis of Ankle Pseudoaneurysm Following Ankle Arthroscopy: A Case Report

        Cases archive
          




        my personal edition > orthopaedics other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Alendronate Improves Bone Mineral Density After Total Knee Arthroplasty

        A DGReview of :"The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty"
        Journal of Bone and Joint Surgery. American Volume

        12/11/2003
        By Emma Hitt, PhD


        Oral administration of alendronate for 6 months after total knee arthroplasty appears to improve bone mineral density significantly in the distal part of the femur and proximal part of the tibia, new research suggests.

        The mechanical properties of the trabecular bone in the proximal part of the tibia and the distal part of the femur are considered to be an important predictor of failure after total knee arthroplasty.

        Ching-Jen Wang, MD, with the Kaohsiung Medical Center, Niao-Sung Hsiang, Taiwan, and colleagues hypothesised that alendronate, an antiresorptive bisphosphonate effective for treating osteoporosis, could decrease bone loss and improve outcomes after total knee arthroplasty.

        In their study, 96 women, average age 70 years, who were undergoing total knee arthroplasty were randomised to receive oral alendronate at a dose of 10 mg/day for 6 months or no alendronate (controls).

        The researchers determined bone mineral density in the distal part of the femur and proximal part of the tibia preoperatively and at 6 and 12 months postoperatively.

        In the control group, bone mineral density decreased by 13.8% (P < .001) and 7.8% (P = .003) in the distal part of the femur and by 6.5% (P = .002) and 3.6% (P = .141) in the proximal part of the tibia at 6 and 12 months, respectively.

        In contrast, the bone mineral density of the study group increased by 10.0% (P = .010) and 1.9% (P = .049) in the distal part of the femur and by 9.4% (P < .001) and 5.4% (P = .032) in the proximal part of the tibia at 6 and 12 months, respectively.

        According to Dr. Wang and colleagues, the overall differences in bone mineral density between the study and control groups were significant (P = .011 for the proximal part of the tibia, and P = .033 for the distal part of the femur).

        "The bone mineral density changes beyond one year are unknown at the present time, and additional studies are needed to determine the long-term effects of alendronate," the researchers note.

        "The better bone density that was found after treatment with alendronate may lead to better fixation of prosthetic components, increased longevity of total knee prostheses, and a reduced risk of periprosthetic fracture," they suggest.



        J Bone Joint Surg Am 2003;85:2121-2126. "The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send